#France #Qaelon Medical #Surgical Leaks #Strasbourg #Dr. Andrew Storm

Qaelon Medical's New Chapter: Scientific Advisory Board Formation

Qaelon Medical, a frontrunner in real-time surgical leak detection and advanced insufflation technologies, has recently unveiled its establishment of a Scientific Advisory Board (SAB). The board aims to shape the clinical development and innovation strategies for Qaelon's pioneering AI-assisted platform, which seeks to address the pressing issues of surgical leaks and perforations encountered during minimally invasive surgeries, including procedures involving endoluminal robotics and advanced therapeutic endoscopy.

The appointment of Dr. Andrew Storm, M.D., FASGE, as Chair of the SAB, marks a significant milestone for Qaelon Medical. Dr. Storm is an accomplished endoscopist and serves as the Chair of Endoscopy at the renowned Mayo Clinic in Rochester, Minnesota. His invaluable expertise in therapeutic endoscopy and device innovation aligns perfectly with Qaelon's mission to elevate the standards of endoscopic procedures by integrating real-time detection capabilities for leaks and perforations with advanced insufflation methods.

Eran Shlomovitz, M.D., FRCPC, FRCSC, FACS, the Chief Medical Officer of Qaelon Medical, expressed enthusiasm about the formation of the board. He stated, “We are thrilled to launch our Scientific Advisory Board with Dr. Storm, whose expertise in therapeutic endoscopy and device innovation perfectly complements our mission to revolutionize endoscopic procedures.” Shlomovitz added that Dr. Storm’s leadership would be crucial as the company accelerates clinical trials and works towards bringing its life-saving platform to market.

Dr. Storm elaborated on the transformative potential of the SAB, remarking, “Therapeutic endoscopy and endoluminal robotics are experiencing rapid innovation, enabling less invasive approaches to complex procedures such as endoscopic submucosal dissection (ESD), endobariatrics (ESG), endoscopic ultrasound-guided (EUS) gastrointestinal anastomosis, and endoscopic full-thickness resection (EFTR). Despite this progress, existing technologies for leak detection and insufflation have limitations that hinder adoption.” He is optimistic that Qaelon's platform will fill critical gaps in the realm of endoscopic and bariatric interventions.

Liam Burns, the CEO of Qaelon Medical, emphasized the shortcomings of current leak detection methodologies in intraluminal surgery—stressing the risks to patients which may result in serious complications such as sepsis or the need for reoperation. He stated, “Qaelon's cutting-edge platform aims to address these challenges head-on, providing real-time detection of leaks and perforations, precision constant-flow insufflation, and AI-assisted analytics.” The integration of Dr. Storm’s expertise is seen as pivotal in enhancing patient safety and paving the way for a shift in the clinical landscape.

Located in Strasbourg, France, Qaelon Medical is on a mission to redefine the future of surgical leak detection and insufflation technologies. Their platform represents groundbreaking progress, combining real-time, AI-driven leak detection with constant-flow insufflation, tailored for minimally invasive procedures. This innovative approach not only replaces outdated visual tests with contemporary digital sensors but also utilizes advanced algorithms to empower surgeons with in-the-moment intervention capabilities. The objective: to minimize complication rates, shorten hospital stays, and lower healthcare costs over time.

Currently, Qaelon Medical's products remain under development and have yet to receive clearance from regulatory bodies like the FDA for commercial distribution in the United States and Europe. As they prepare to unveil additional members of the Scientific Advisory Board in the coming weeks, the excitement surrounding Qaelon Medical's future endeavors and advancements in surgical technologies continues to build. This initiative appears poised to significantly improve patient outcomes in complex surgical procedures.

For more information, visit Qaelon Medical's official website or contact Yee Ying Douchamps at [email protected]